D. Boral Capital Reiterates Buy Rating for UroGen Pharma (NASDAQ:URGN)
UroGen Pharma (NASDAQ:URGN – Get Free Report)‘s stock had its “buy” rating restated by stock analysts at D. Boral Capital in a research note issued...
Keefe, Bruyette & Woods Lowers Essent Group (NYSE:ESNT) Price Target to $71.00
Essent Group (NYSE:ESNT – Get Free Report) had its price objective cut by stock analysts at Keefe, Bruyette & Woods from $72.00 to $71.00 in...
Ecopetrol (NYSE:EC) Stock Rating Upgraded by Citigroup
Ecopetrol (NYSE:EC – Get Free Report) was upgraded by Citigroup from a “neutral” rating to a “buy” rating in a report issued on Tuesday, MarketBeat...
First American Financial (NYSE:FAF) Price Target Raised to $75.00 at Keefe, Bruyette & Woods
First American Financial (NYSE:FAF – Get Free Report) had its price objective upped by equities research analysts at Keefe, Bruyette & Woods from $74.00 to...
Barclays Downgrades Moderna (NASDAQ:MRNA) to Equal Weight
Moderna (NASDAQ:MRNA – Get Free Report) was downgraded by research analysts at Barclays from an “overweight” rating to an “equal weight” rating in a research...
Needham & Company LLC Reaffirms Hold Rating for Dynatrace (NYSE:DT)
Dynatrace (NYSE:DT – Get Free Report)‘s stock had its “hold” rating reissued by equities researchers at Needham & Company LLC in a research report issued...
